The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Sanofi Can Produce Millions of Doses of HCQ, Potential Coronavirus Drug

Sanofi Can Produce Millions of Doses of HCQ, Potential Coronavirus Drug

April 3, 2020 • By Matthias Blamont & Michael Erman

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Sanofi has fielded requests for the drug, which is also used to treat lupus and rheumatoid arthritis, from countries all over the world, Hudson said.

You Might Also Like
  • Sanofi, Regeneron Expand Testing of Potential Coronavirus Treatment
  • Sanofi, Regeneron Begin Testing Arthritis Drug as Coronavirus Treatment
  • Data on Arthritis Drug to Treat Coronavirus Could Come within Weeks

He added that Sanofi is working with other companies to make sure the supply of HCQ is as broad as possible.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“We just tried to coordinate a little bit to say to companies, ‘Let’s all not end up supplying the same market. Let’s make sure that everybody has a chance that needs it,'” Hudson says. If one area is well supplied, he added, “then we’re happy to help somewhere else.”

There is still much to learn about who is most likely to be helped by the drug and at what dose before companies can accurately estimate supply demand if the treatment proves effective.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“It’s important to know whether you would give it to mild patients or severe patients,” Hudson explains. “The sheer volume difference in those patients is significant.”

Pages: 1 2 | Single Page

Filed Under: Drug Updates Tagged With: coronavirus, COVID-19, HCQ, Hydroxychloroquine (HCQ), Sanofi

You Might Also Like:
  • Sanofi, Regeneron Expand Testing of Potential Coronavirus Treatment
  • Sanofi, Regeneron Begin Testing Arthritis Drug as Coronavirus Treatment
  • Data on Arthritis Drug to Treat Coronavirus Could Come within Weeks
  • Regeneron Plans Early Summer Trials for New Antibodies Against Coronavirus

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)